Németh, János, Tapasztó, Beáta, Aclimandos, Wagih A, Kestelyn, Philippe, Jonas, Jost B, De Faber, Jan-Tjeerd H N, Januleviciene, Ingrida, Grzybowski, Andrzej, Nagy, Zoltán Zsolt, Pärssinen, Olavi, Guggenheim, Jeremy A, Allen, Peter M, Baraas, Rigmor C, Saunders, Kathryn J, Flitcroft, Daniel Ian, Gray, Lyle S, Polling, Jan Roelof, Haarman, Annechien EG, Tideman, J Willem L, Wolffsohn, James Stuart, Wahl, Siegfried, Mulder, Jeroen A, Smirnova, Irina Yurievna, Formenti, Marino, Radhakrishnan, Hema and Resnikoff, Serge (2021). Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European Journal of Ophthalmology, 31 (3), pp. 853-883.
Abstract
The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.
Publication DOI: | https://doi.org/10.1177/1120672121998960 |
---|---|
Divisions: | College of Health & Life Sciences > School of Optometry > Optometry College of Health & Life Sciences > School of Optometry > Optometry & Vision Science Research Group (OVSRG) College of Health & Life Sciences Aston University (General) |
Additional Information: | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
Uncontrolled Keywords: | Myopia,atropine,blindness,myopia reduction interventions,orthokeratology,pathologic myopia,preventive medicine,time spent outdoors,Ophthalmology |
Publication ISSN: | 1724-6016 |
Last Modified: | 13 Dec 2024 08:21 |
Date Deposited: | 15 Mar 2021 09:53 |
Full Text Link: | |
Related URLs: |
https://journal ... 120672121998960
(Publisher URL) http://www.scop ... tnerID=8YFLogxK (Scopus URL) |
PURE Output Type: | Review article |
Published Date: | 2021-05 |
Published Online Date: | 2021-03-05 |
Accepted Date: | 2021-02-04 |
Authors: |
Németh, János
Tapasztó, Beáta Aclimandos, Wagih A Kestelyn, Philippe Jonas, Jost B De Faber, Jan-Tjeerd H N Januleviciene, Ingrida Grzybowski, Andrzej Nagy, Zoltán Zsolt Pärssinen, Olavi Guggenheim, Jeremy A Allen, Peter M Baraas, Rigmor C Saunders, Kathryn J Flitcroft, Daniel Ian Gray, Lyle S Polling, Jan Roelof Haarman, Annechien EG Tideman, J Willem L Wolffsohn, James Stuart ( 0000-0003-4673-8927) Wahl, Siegfried Mulder, Jeroen A Smirnova, Irina Yurievna Formenti, Marino Radhakrishnan, Hema Resnikoff, Serge |